Results of the BELLE-3 study of buparlisib for advanced breast cancer ecancer 5:42 7 years ago 123 Далее Скачать
Buparlisib helps overcome endocrine resistance in metastatic breast cancer: BELLE-2 trial results ecancer 7:02 8 years ago 376 Далее Скачать
Case 3: Results of the IMpassion130 Trial in Metastatic Breast Cancer Targeted Oncology 6:33 4 years ago 220 Далее Скачать
Overall survival results from MONALEESA-3 study on ribociclib plus fulvestrant in advanced breas... ecancer 3:09 5 years ago 216 Далее Скачать
Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets HMP Education 31:21 7 years ago 3 180 Далее Скачать
Discussing the Latest Results From the MONALEESA-3 Study Targeted Oncology 3:42 6 years ago 107 Далее Скачать
Alpelisib and Buparlisib Blocks Tamoxifen Resistance related Cancer Recurrence? Christine Song 24:18 4 years ago 357 Далее Скачать
Design and results of Phase III FALCON trial of fulvestrant for advanced breast cancer VJOncology 2:17 8 years ago 239 Далее Скачать
MONARCH 3 study: CDK4/6 inhibitors in the treatment of metastatic breast cancer VJOncology 4:54 7 years ago 746 Далее Скачать
PALOMA-3: Phase 3 trial of fulvestrant with palbociclib for metastatic breast cancer EMJ 2:45 9 years ago 1 025 Далее Скачать
MONALEESA-3 OS results: fulvestrant/ribociclib in postmenopausal HR+/HER2- advanced breast cancer VJOncology 10:15 5 years ago 980 Далее Скачать
PALOMA-3: Palbociclib plus fulvestrant in hormone receptor-positive advanced breast cancer EMJ 3:02 9 years ago 1 651 Далее Скачать
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-mutated/HR+/HER2-... ecancer 3:53 5 years ago 2 300 Далее Скачать
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer ecancer 1:46 7 years ago 154 Далее Скачать
Analyses from PALOMA-3 study, including OS data for HR+ breast cancer ecancer 6:56 6 years ago 154 Далее Скачать
Everolimus extends PFS for HR positive, HER2 negative breast cancer ecancer 7:06 7 years ago 178 Далее Скачать
PALOMA-3: palbociclib and fulvestrant for HR-/HER+ metastatic breast cancer VJOncology 5:04 6 years ago 1 373 Далее Скачать
